Is Jaundice Common in Babies? Causes and Treatment

Jaundice is one of the most common conditions in newborns. Roughly 50% of full-term babies and 80% of premature babies develop visible jaundice in the first week of life. In the vast majority of cases, it’s harmless and resolves on its own within about ten days. But understanding what’s normal, what raises the risk, and what warning signs to watch for can make a real difference in catching the rare cases that need treatment.

Why Nearly Every Newborn Gets Some Jaundice

Jaundice happens when a substance called bilirubin builds up in the blood faster than a baby’s body can get rid of it. Bilirubin is a byproduct of red blood cells breaking down, and newborns produce more of it than adults because they’re born with extra red blood cells they no longer need outside the womb. At the same time, a newborn’s liver is still immature and slow at processing bilirubin for removal. This combination of high production and slow clearance is why bilirubin levels spike in nearly every baby during the first few days.

This “physiological jaundice” is so expected that many pediatricians consider it a normal part of the transition to life outside the womb. It’s common in newborns but rare later in life, because once the liver matures and the extra red blood cells are cleared, the bottleneck disappears.

Typical Timeline: When It Appears and Fades

In full-term babies, jaundice typically becomes visible around the third or fourth day of life. It peaks on the fifth or sixth day and usually fades by day ten. Premature babies tend to develop jaundice earlier and it can last longer, partly because their livers are even less mature.

The yellowing follows a predictable pattern on the body. It starts on the face and head, then gradually spreads downward to the chest, belly, and finally the legs and feet. If you only see a slight yellow tint on your baby’s face, bilirubin levels are likely on the lower end. Yellowing that extends to the trunk or below suggests higher levels. That said, research published in JAMA Pediatrics found that visual assessment of jaundice is surprisingly unreliable. Agreement between trained clinicians looking at the same baby was poor, and the correlation between how yellow a baby looks and actual bilirubin levels is weak. Skin tone, lighting, and observer experience all introduce error, which is why hospitals rely on actual bilirubin measurements rather than eyeballing it.

How Bilirubin Levels Are Checked

There are two main ways to measure bilirubin. The first is a skin-based device (transcutaneous bilirubinometer) that’s pressed against the baby’s forehead or chest and gives a reading in seconds with no needles. It’s a useful screening tool, but it tends to overestimate actual bilirubin levels, especially in babies with darker skin tones. One study found the device overestimated bilirubin by a clinically meaningful amount in more than 60% of measurements in Black African newborns. It rarely underestimates, though, which means it’s better at ruling jaundice out than confirming exactly how high levels are.

When the skin reading is elevated or the baby has risk factors, a blood draw confirms the exact bilirubin level. This blood test is what doctors use to decide whether treatment is needed. The threshold for starting treatment depends on the baby’s age in hours, gestational age, and whether other risk factors are present.

Risk Factors That Raise the Odds

While jaundice affects most newborns to some degree, certain babies are more likely to develop levels high enough to need treatment:

  • Blood type mismatch. If a mother’s blood type differs from her baby’s, the baby may have received antibodies through the placenta that cause red blood cells to break down faster than normal, flooding the system with bilirubin.
  • Bruising during delivery. Babies who are bruised during birth break down more red blood cells in the bruised tissue, which increases bilirubin production.
  • Premature birth. Babies born before 38 weeks have less mature livers and are at higher risk for levels that need intervention.
  • Family history. If a parent or sibling needed treatment for jaundice as a newborn, the baby’s risk is higher.
  • Certain enzyme deficiencies and infections. Conditions that cause red blood cells to break down more quickly, or sepsis, increase the risk of dangerously high levels.

Ethnicity and genetic variants also play a role. Nutrition and feeding patterns in those early days further influence how quickly bilirubin clears.

The Breastfeeding Connection

Two distinct types of jaundice are linked to breastfeeding, and they’re often confused with each other.

The first, sometimes called breastfeeding jaundice, shows up in the first week of life when milk supply is still being established and the baby isn’t getting enough volume. Low intake means fewer bowel movements, and bilirubin that would normally leave through stool gets reabsorbed back into the bloodstream. The fix is straightforward: more frequent feedings. Breastfeeding should continue, and increasing the number of feeds helps move bilirubin out.

The second type, breast milk jaundice, is different. It appears in the second week of life or later and can persist for several weeks. The exact cause isn’t fully understood, but something in the mother’s milk appears to slow the liver’s ability to process bilirubin. Despite its longer duration, it’s rarely dangerous. Phototherapy is used if levels climb high enough. In rare cases, doctors may suggest briefly supplementing with formula or interrupting breastfeeding for 12 to 48 hours to confirm the diagnosis, but most babies continue breastfeeding without interruption.

How Jaundice Is Treated

Most jaundice needs no treatment at all. For the minority of babies whose bilirubin climbs above treatment thresholds, phototherapy is the standard approach. The baby is placed under special blue lights (or on a light-emitting blanket) that change the structure of bilirubin in the skin, making it easier for the body to eliminate. Phototherapy is painless, and babies typically stay under the lights for one to two days, with periodic blood tests to track levels.

The treatment threshold isn’t a single number. It varies based on how many hours old the baby is, whether they were born early, and whether any additional risk factors are present. A bilirubin level that’s completely safe at 72 hours of age might warrant treatment at 24 hours. This is why hospitals track the baby’s age in hours, not just days.

In very rare and severe cases where phototherapy isn’t enough, a blood exchange transfusion can rapidly lower bilirubin levels. This is uncommon in countries with routine newborn screening.

When Jaundice Becomes Dangerous

The reason hospitals monitor jaundice closely isn’t because of the jaundice itself. It’s because extremely high bilirubin can cross into the brain and cause permanent damage, a condition called kernicterus. This is rare, but it progresses in recognizable stages.

Early signs include extreme sleepiness, poor feeding, weak sucking, and the baby not startling in response to loud sounds. If untreated, this progresses to irritability, a high-pitched cry, and increasingly stiff muscles. In the late stage, the baby may arch their back, stop feeding entirely, and have seizures. Once brain damage from kernicterus occurs, it is irreversible. Long-term consequences include hearing loss, cerebral palsy, and problems with cognitive development.

Kernicterus is almost entirely preventable with timely screening and treatment. The babies most at risk are those discharged from the hospital before bilirubin levels have peaked (which, remember, happens around day five or six) and those whose rising levels go unrecognized. If your baby looks increasingly yellow, is difficult to wake for feedings, or seems unusually floppy or stiff, those are reasons for an urgent bilirubin check.